Tier 2 — strong
Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
The Journal of clinical endocrinology and metabolism
2024
109(8):1907-1947
Bibliography
- PubMed
- PMID 38828931
- Funding
- Support is recorded from The Endocrine Society. See the original publication for grant and material-support details.
- Competing interests
- A competing-interest declaration is not available in the indexed abstract or accessible disclosure metadata.
Study snapshot
| Design | GRADE-based clinical practice guideline |
|---|---|
| Model | Human evidence synthesis |
| Sample | Guideline panel addressing 14 prioritized clinical questions |
| Intervention | Population-specific vitamin D prevention recommendations |
| Duration | Not a new intervention; evidence-based guidance published in 2024 |
| Endpoints | Disease prevention; Dosing approach; Vitamin D testing |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
- Vitamin D Blood Tests: 25(OH)D Levels, Units and When Testing HelpsUnderstand 25(OH)D blood tests, ng/mL and nmol/L conversions, interpretation frameworks, and when testing can change care.Read analysis
- Vitamin D3 Dosage: Daily Needs, 5,000 IU and Higher DosesCompare adult D3 reference intakes, 1,000–10,000 IU strengths, UK guidance, higher-dose research and when follow-up matters.Read analysis
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified
Biohack Blueprint Research
